Bone Grafts and Substitutes Market will be worth US$3.48 bn

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
90
Bone Grafts and Substitutes Market will be worth US$3.48 bn by the end of 2023, Says TMR

Albany, NY, Aug. 06, 2018 (GLOBE NEWSWIRE) -- TMR estimated the global revenue of the bone grafts ad substitutes market is expected to grow at a CAGR of 4.5% over the forecast period from 2015 to 2023. With this rate, the market is expected to attain value of US$3.48 bn by the end of the 2023. In 2015, market in North America accounted for the larger share in the global market for bone grafts and substitutes. This growth is attributable to presence of large number of key players coupled with increasing number of innovations in the region. Thanks to these factors, the revenue of the region is estimated to reach the value of US$1.23 bn by the end of 2023. Applications of bone grafts and substitutes in spinal fusion is expected to dominate and expand with a CAGR of 4.4%.

Request to View Sample of Report - https://www.transparencymarketresearch.com/sa...ep_id=6200

Demand for Novel Treatment of Numerous Bone Disorders to Propel Growth

Prevalence of bone and joint disorders are growing, says the report of Centers for Disease Control and Prevention (CDC). The reports mentioned that more than 67mn people in the US are expected to detect the diseases such as arthritis by the end of 2030. This concludes that arthritis is one of the leading factor responsible for disorders. As a novel cure, the number of orthopedic surgeries will be increased which in turn the boost the adoption of the bone grafts and substitutes. This factor is booting growth of the global bone grafts and substitutes market.

Request PDF Brochure of Report: https://www.transparencymarketresearch.com/sa...ep_id=6200

Bone grafts and substitutes are the material that promote healing process of bone, osseous reconstruction, and improves bone formation due to their properties such as osteogenic, osteoinductive, and osteoconductive. The bone grafts and substitutes are mainly used in the sports, facial, trauma plastic, and spinal surgery for replacing a missing or bone with material from body of patient. These are boosted uptake of the global bone grafting and substitutes which is likely to propel growth of the global market for bone grafts and substitutes market.

Request For Discount On This Report: https://www.transparencymarketresearch.com/sa...ep_id=6200

Increasing Incidences for Bone Disorder among Geriatric Population to Fuel Growth

Some of the technological advancements in the medical field for development of compatible bone grafting increase in demand for dental bone grafts drive the market growth.

Despite of this growth, high cost of surgeries are hampering growth of the global bone grafts and substitutes market. Some issues related to demand and supply of bone grafting are crimping growth of the global market for bone grafts and substitutes. Additionally, several stringent regulations imposed on the usage of bone grafts and substitutes to withdraw risk of infections. These factors are expected to restrict the growth of the market Nevertheless, launch of innovative substitutes in re bone grafts and substitutes market having potential opportunities to fuel growth of the market. Furthermore, high demand from geriatric population mainly for the treatment of the diseases like arthritis are creating lucrative opportunities in the key players in the global bone grafting and substitutes market.

Request For Custom Research: https://www.transparencymarketresearch.com/sa...ep_id=6200

The global bone grafts and substitutes market is consolidated with leading companies, finds Transparency Market Research (TMR). Some of the key players operating in the bone grafts and substitute market include DePuy Synthes, Nuvasive, Inc., Medtronic, Wright Medical Group, Inc., and Zimmer Biomet. The three companies such as Stryker Corporation, Medtronic, and Zimmer accounts for more than 50% of shares in the market. Players operating in the market are struggling for a sustainable growth for expansion of the business and offering additional services for improving the relationship with consumers. For business expansion, the key players have adopted the key trends including acquisition, mergers and partnership.

Request For Multiple Chapters: https://www.transparencymarketresearch.com/sa...ep_id=6200

This information is from the new report by TMR, titled “Bone Grafts and Substitutes Market (Type - Allografts (Demineralised Bone Matrix) and Bone Graft Substitutes (Bone Morphogenic Proteins (BMP) and Synthetic Bone Grafts); Application - Spinal Fusion, Long Bone, Foot and Ankle, Craniomaxilofacial, Joint Reconstruction, and Dental) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2015 - 2023.” 

More Trending Reports by Transparency Market Research -

Bone Densitometers Market: https://www.transparencymarketresearch.com/bo...arket.html

Bone Degeneration Therapeutics Market : https://www.transparencymarketresearch.com/bo...arket.html

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Mr. Nachiket Ghumare Transparency Market Research State Tower 90 State Street, Suite 700, Albany, NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email : sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com Research Blog: http://theglobalhealthnews.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Huawei Introduces Innovative Wearables for Enhanced Connectivity

Updated Category News Views 293

Huawei Unveils Next-Generation Wearables and Tablets At a much-anticipated event, Huawei Consumer Business Group (CBG) revealed a thrilling array of new products. This launch showcased a strong emphasis on trendy wearables and sophisticated tablets, highlighting the brand's dedication to innovation and a user-friendly design. Chic Wearables for Style and Utility Among the...

Continue Reading
Investigating Barnes & Noble Education: Shareholder Rights Explained

Updated Category News Views 155

Understanding the Investigation of Barnes & Noble Education In a proactive move for investors, the law firm Bragar Eagel & Squire, P.C. is currently investigating Barnes & Noble Education, Inc. (BNED). This investigation aims to determine whether the company potentially breached federal securities laws or engaged in unlawful business practices that could lead to...

Continue Reading
Bailey Kennedy Achieves Landmark Legal Win for Talisman Group

Updated Category News Views 171

Bailey Kennedy Achieves Legal Victory for Talisman Group Judge Rules LNW Violated Talisman's Distribution Agreement by Marketing Competing Game In a significant legal development, Bailey Kennedy, LLP has successfully represented The Talisman Group, LLC, the innovative minds behind EZ Baccarat. The firm has recently triumphed in a legal dispute against LNW Gaming, Inc.,...

Continue Reading
Join the Class Action Lawsuit Against Ardelyx, Inc. Now

Updated Category News Views 49

Join the Class Action Lawsuit Against Ardelyx, Inc. Attention Ardelyx, Inc. investors! There's an important class action lawsuit underway, and this is your opportunity to get involved. Bronstein, Gewirtz & Grossman, LLC, a respected law firm known for its dedication to investor advocacy, has announced a class action case involving Ardelyx, Inc. (NASDAQ: ARDX) and certain...

Continue Reading
Aileron Therapeutics Unveils Q3 2024 Financial Performance

Updated Category News Views 97

Aileron Therapeutics Reports Impressive Q3 2024 Financial Results Aileron Therapeutics, Inc. (NASDAQ: ALRN), a biopharmaceutical company committed to developing innovative medicines for orphan pulmonary diseases, has recently showcased significant progress with their third-quarter financial results. This quarter has been marked by promising advancements in clinical trials...

Continue Reading